Skip to main content
logo
Nextage Therapeutics Ltd (TLV:NXTG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
38.80
-0.10 (-0.26%)
Sep 23, 2026, 3:38 PM IDT

Nextage Therapeutics Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.513.63.237.63-0.09
Revenue Growth
-30.18%11.57%-57.71%---52.36%
Gross Profit
-0.80.3-0.721.16-0.02
Operating Income
-12.3-8.15-5.47-5.32-5.85-7.12
Net Income
-15.84-6.06-8.821.89-5.59-7.73
Earnings Per Share
-0.22-0.14-0.170.06-0.20-0.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.050.310.010.481.13-
Total Debt
7.6517.3412.040.380.33-
Net Cash (Debt)
-7.61-17.04-12.020.10.8-
Net Cash Growth
----87.30%--
Net Cash Per Share
-0.10-0.41-0.230.000.03-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.57-6.510.65-3.39-6.01-3.97
Capital Expenditures
-0-0--0.04-0-
Free Cash Flow
-10.57-6.510.65-3.42-6.02-3.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-31.89%8.28%-22.42%15.15%-17.58%
Operating Margin
-489.57%-226.46%-169.67%-69.76%--7825.28%
Pretax Margin
-635.67%-174.43%-273.49%41.54%--8717.58%
Profit Margin
-630.69%-168.48%-273.49%24.84%--8492.31%
FCF Margin
-420.78%-180.91%20.12%-44.89%--4367.03%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--36.61---
PS Ratio
12.557.307.37---